ABSTRACT
Esophageal squamous cell carcinoma (ESCC) prognosis is known to be dismal among gastrointestinal cancers. 1, 2 This is partly because ESCC with lymph node metastasis (LNM) frequently recurs, even after curative resection. 3 LNM is reportedly observed in about 20% to 50% of superficial ESCCs, which is characterized by submucosal invasion. 1, [4] [5] [6] [7] [8] [9] Recently, the incidental detection of superficial ESCC has increased as advances in diagnostic technology using narrow-band imaging have been implemented.
LNM is known to be a significant prognostic factor for all disease stages. [10] [11] [12] Survival rates of patients with pT1 to pT2 tumors without LNM who were confirmed using pathologic examination after surgical resection accompanied with three-field lymph node dissection were significantly longer than those of patients with pT1 to pT2 tumors with LNM. 13 Previous studies have reported that several clinicopathologic factors, including macroscopic type (0-I, superficial and protruding type; 0-III, superficial and excavated type), 7 tumor size, 7,14 depth of tumor invasion (pSM2 or pSM3), 6, 8, 15, 16 tumor differentiation, infiltrative growth pattern (INF), 17 and lymphovascular infiltration, 1, 5, 7, 8, [14] [15] [16] [17] [18] [19] [20] [21] are sensitive and specific predictors of LNM. However, even a combination of these risk factors for LNM described above has not enabled the prediction of LNM with complete accuracy.
Some studies have reported that the submucosal layer subclassification of tumor invasive depth into three groups (SM1-SM3) can be used as a significant predictor © American Society for Clinical Pathology AJCP / Original article of LNM 6, 8, 15, 16 ; however, the SM1 to SM3 subclassification is not consistent with the actual submucosal invasive depth (SID) among cases and does not reflect the absolute submucosal invasive distance. Moreover, the relationship between LNM and SID that was measured as a vertical distance from the muscularis mucosae (MM) line to the deepest portion of the invasive carcinoma cell has not been previously investigated.
The aim of the present study was to explore sensitive and specific risk factors for the accurate prediction of LNM in patients with ESCC with submucosal invasion and examine whether these risk factors had an impact on prognosis. The understanding of risk factors for LNM paves the way for selecting those patients with submucosal invasive ESCC who would need additional therapy, which may lead to improving patient prognosis in the near future.
Materials and Methods

Patients
A total of 737 patients with ESCC who underwent surgical resection accompanied by a three-field lymph node dissection at the National Cancer Center Hospital East between January 2006 and December 2013 were eligible for inclusion in the present study. Of these patients, those who underwent surgical resection and were pathologically diagnosed as having ESCC with submucosal invasion (submucosal invasive ESCC) were enrolled in this study.
Patients who had received neoadjuvant chemotherapy and/or radiotherapy were excluded from the study. In contrast, patients who underwent surgical resection after endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) because of noncurative resection were enrolled. For patients with multiple synchronous ESCC lesions, the ESCC lesion with the deepest invasive depth was evaluated in the present study. Clinical tumor depth was determined using endoscopic examination and enhanced computerized tomography or endoscopic ultrasonography (EUS) with 20-MHz miniature probes.
LNM was assessed based on the pathologic findings of the lymph nodes dissected at the time of the surgical resection. Recurrence-free survival (RFS) was defined as the period from the date of surgery until the date on which recurrence was clinically confirmed. Overall survival (OS) was also defined as the period until the date on which death was clinically confirmed. This study was retrospectively performed at a single institution, and the institutional review board of the National Cancer Center approved the study protocol (2014-065).
Histopathologic Examinations
Routine pathologic diagnoses of the surgically resected specimens were performed as follows. Each surgically resected esophageal specimen was fixed in 10% neutral buffered formalin and cut into 5-mm slices vertical to the long axis, then processed for paraffin embedding and sectioning. H&E staining was performed and examined using light microscopy.
The following factors were routinely examined: (1) location of the tumor, (2) tumor size (maximum tumor diameter), (3) macroscopic type, (4) histologic subtype including differentiation, (5) INF, (6) tumor depth, (7) SID, (8) lymphatic infiltration of tumor cells (LY), (9) venous infiltration of tumor cells (V), and (10) lymphovenous infiltration (LVI; positive for LY and/or V). In addition, each surgically dissected lymph node was handled in the same way as described above.
These factors were evaluated based on the Japanese Classification of Esophageal Cancer. 22 Tumor size was measured after mapping the tumor range confirmed using light microscopy as shown in ❚Image 1A❚ and ❚Image 1B❚. SID was defined as the vertical distance from MM or a virtual line formed by connecting the smooth muscle fibers of MM with the deepest portion of the invasive carcinoma, as shown in ❚Image 1C❚. For surgically resected specimens, tumor depth was classified into three levels as follows: pSM1, a shallow submucosa; pSM2, a middle submucosa; and pSM3, a deeper submucosa. For endoscopically resected specimens, pSM1 was defined as when SID was within 200 μm, and pSM2 was defined as when SID was deeper than 200 μm. V was routinely judged using both H&E-stained and Elastica van Gieson-stained slides ❚Image 2A❚, ❚Image 2B❚, and ❚Image 2C❚. LY was routinely evaluated using H&E-stained slides ❚Image 2D❚ and ❚Image 2E❚. All surgically dissected lymph nodes were routinely examined for the presence of metastasis using H&E-stained slides.
Statistical Analysis
The statistical analysis was performed using the above-mentioned LNM predictors. The maximum tumor diameter was analyzed in terms of the change in odds per millimeter. The macroscopic type was classified as 0 to I or 0 to IIa/0 to IIc. The tumor depth was classified as SM1 or SM2/SM3. SID was analyzed in terms of the change in odds per micrometer. LY, V, and LVI were classified as positive or negative. A univariate analysis was performed by applying a two-sample Student t test for the maximum tumor diameter and SID and the χ 2 test or Fisher exact test for other factors for assessing the relationship between LNM predictors and the rate of LNM. The areas under the receiver operating characteristic (ROC) curves were used for the maximum tumor diameter and SID to clarify the cutoff values for LNM.
A multiple logistic regression analysis using the forward selection method was conducted for those factors that were statistically significant in the univariate analysis, and the relationship between such factors and LNM was assessed. In addition, RFS and OS cures were estimated using the Kaplan-Meier method and compared using the log-rank test. The univariate Cox proportional hazards model was used to examine the association between clinicopathologic factors and RFS or OS. Variables with a P value less than .05 were evaluated simultaneously using a multivariate analysis with the Cox proportional hazards model. All variables were deemed significant if P < .05. All data were analyzed using SPSS software (version 22.0 for Mac; SPSS, Chicago, IL).
Results
Clinicopathologic Characteristics
The clinicopathologic characteristics of the 108 patients who were enrolled in this study are shown in ❚Table 1❚. Of these patients, 12 had undergone endoscopic resection (two cases involved EMR and 10 cases ❚Image 1❚ A representative case. A, Macrographs of the formalin-fixed specimen. The type 0 to IIa + IIc tumor was located in the middle portion of the thoracic esophagus. B, Macrographs of the formalin-fixed specimen after Lugol's staining. The tumor was not stained with Lugol's solution. The tumor size was measured by mapping the tumor cell distribution under microscopic examination. The maximum tumor diameter of this tumor was 88 mm. C, Photomicrographs of the H&E-stained sections of the specimen. The photomicrographs consisted of two consecutive slides (×20; insets, ×40). Invasion of tumor cells into the submucosa was accompanied by destruction of the muscularis mucosae (MM), after identification of the MM around the tumor (the MM is indicated by the arrows in the square boxes). The virtual line is shown as a dotted line connecting the MM at both sides of the tumor. Submucosal invasive depth (SID) is shown as (↔) and was measured from the virtual line to the deepest portion of tumor tissue. SID in the specimen was 2,750 µm. involved ESD), followed by surgical resection because of noncurative resection. EUS was performed to determine the clinical tumor depth before treatment for 27 cases. Clinical tumor depths were cMM or cSM1 (15 cases, 13.9%), cSM2 or cSM3 (73 cases, 67.6%), and muscularis propria (cMP) or adventitia (cAD) (20 cases, 18.5%). The mean and median (range) of the maximum tumor diameter were 31 and 25 (4-110) mm, respectively. The macroscopic types were types 0 to I (31 cases, 28.7%), types 0 to IIa (20 cases, 18.5%), and types 0 to IIc (57 cases 52.8%). The depth of invasion was pSM1 in 10 cases and pSM2/pSM3 in 98 cases. SID measured pathologically was 0 to 1,000 μm in 27 cases, 1,000 to 2,000 μm in 37 cases, and 2,000 μm or deeper in 44 cases. The positive rates of LY and V were 33.3% (36 cases) and 52.8% (57 cases), and LVI was observed in 74 (68.5%) cases. Among the 108 cases, 42 (38.9%) had LNM. In addition, 12 patients with LNM were treated with adjuvant chemotherapy.
Predictors of LNM
The median (range) of the number of LNMs was 2 (1-12). ❚Table 2❚ shows the clinicopathologic characteristics according to positivity or negativity for LNM. Univariate analyses showed that tumor size (P = .0072), SID (P = .0011), LY (P < .0001), and LVI (P = .036) were significantly correlated with LNM. As shown in ❚Figure 1A❚, the areas under the ROC curves of SID and tumor size in the presence of LNM were 0.720 and 0.691, respectively, and these values were statistically significant (SID: 95% confidence interval [CI], 0.622-0.819, P = .00012; tumor size: 95% CI, 0.590-0.792, P = .00085). The cutoff values of SID and tumor size in the presence of LNM were determined to be 1,912.5 μm and 35.5 mm, respectively. Based on these results, we determined cutoff values for SID and tumor depth as 2,000 μm and 35 mm, respectively ❚Figure 1B❚.
As shown in ❚Table 3❚, a multiple logistic regression analysis was performed on several factors, including a larger tumor size of 35 mm, tumor depth, a SID of 2,000 μm, LY, and LVI. The multivariate analysis revealed that three factors were significant predictors for LNM: a larger tumor size of 35 mm (P = .0025; odds ratio [OR], 4.608), a SID of 2,000 μm (P = .013; OR, 3.285), and LY (P < .0001; OR, 7.270). An optimal cutoff value of 35 mm for tumor size exhibited a 52.3% sensitivity, a 74.2% specificity, and a 71.0% negative predictive value for LNM ❚Table 4❚. An optimal cutoff value of 2,000 μm for SID in the presence of LNM exhibited a 57.1% sensitivity, a 69.7% specificity, and a 71.9% negative predictive value. LY exhibited a 57.1% sensitivity, an 81.8% specificity, 
Clinicopathologic Characteristics of Tumors According to Clinical Tumor Depth
As shown in ❚Table 5❚, the most macroscopic types in tumors that were diagnosed as cMP/cAD were types 0 to I (16 cases, 80.0%). The percentage of type 0 to I tumors was significantly smaller in cMM/cSM1 or cSM2/cSM3 tumors compared with those in cMP/ cAD (cMM/cSM1 vs cMP/AD: P < .0001 and cSM2/ SM3 vs cMP/cAD: P < .0001). There was a significant difference in pathologic SID between tumors with cMM/cSM1 and those with cMP/cAD, as well as between cSM2/cSM3 and cMP/cAD (cMM/cSM1 vs cMP/cAD: P < .0001, cSM2/cSM3 vs cMP/cAD: P = .0070). Although there was no correlation between LY and clinical tumor depth, the rate of V positivity in tumors with cMP/cAD (90.0%) was significantly 
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Kadota et al / SubmucoSal InvaSIve Depth preDIctS lnm In Sm-eScc higher compared with those in tumors with cMM/ cSM1 (26.7%) (P = .00023) or cSM2/SM3 (47.9%) (P = .00071). However, there was no significant correlation between clinical tumor depth and LNM diagnosed pathologically.
Clinicopathologic Factors Have an Impact on RFS and OR
The median (range) follow-up time was 36 (2-103 months) from the date of surgery. The RFS curves and OS curves according to LNM are shown in ❚Figure 3❚. There was a significant difference for both RFS and OS between patients with LNM and patients without LNM (RFS: P = .022, OS: P = .032). RFS and OS curves according to SID (<2,000 μm vs ≥2,000 μm), tumor size (<35 mm vs ≥35 mm), and LY (negativity vs positivity) are shown in ❚Figure 4❚, ❚Figure 5❚, and ❚Figure 6❚, respectively. For RFS curves, there were significant differences between patients with a SID less than 2,000 μm or not and patients with a tumor size less than 35 mm or not (SID: P = .029, tumor size: P = .049). 
Discussion
In our study, SID was an independent significant predictor of LNM in patients with submucosal invasive ESCC, in addition to tumor size and LY.
Moreover, most patients with LNM could be identified using a combination of these three factors. Tumor size and SID were also associated with a poor prognosis. Some previous reports evaluated tumor depth as a predictor of LNM in esophageal cancer, comparing mucosal invasion with submucosal invasion 1, 5, 7, 8 or SM1 with SM2/3. 15, 16 Among these reports, however, some did not show any significant differences. 1, 5, 7, 18 Based on these studies, we hypothesized that the tumor depth classification described above might be insufficient to predict LNM; thus, we evaluated SID in the present study.
A B
❚Figure 4❚ Recurrence-free survival (RFS) and overall survival (OS) curves in patients with or without a submucosal invasive depth (SID) of 2,000 μm or deeper. A, The RFS curves according to SID. There was a significant difference between patients with a SID of less than 2,000 μm and a SID of 2,000 μm or deeper (P = .029). B, OS curves according to SID. There was no significant difference between patients with a SID less than 2,000 μm and a SID of 2,000 μm or deeper (P = .102).
❚Figure 3❚ Recurrence-free survival (RFS) and overall survival (OS) curves according to the presence or absence of lymph node metastasis (LNM). A, The RFS curves according to LNM. There was a significant difference between LNM-positive and LNM-negative patients (P = .022). B, OS curves according to LNM. There was a significant difference between LNM-positive and LNM-negative patients (P = .032).
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AJCP / Original article Two previous reports found that tumor size was a significant predictor of LNM. 7, 14 Both of these reports described a cutoff value of 20 mm, which was smaller than the present result. However, these previous studies included patients with ESCC with mucosal invasion; therefore, tumor size tended to be relatively small. For this reason, a cutoff value of 35 mm for tumor size in the presence of LNM seems to be appropriate for patients with ESCC with submucosal invasion. We tried to predict LNM preoperatively and clinically, and tumors with A B ❚Figure 5❚ Recurrence-free survival (RFS) and the overall survival (OS) curves in patients with or without tumor sizes of 35 mm or more. A, RFS curves according to tumor size. There was a significant difference between patients with tumor sizes of less than 35 mm and sizes of 35 mm or more (P = .049). B, OS curves according to tumor size. There was no significant difference between patients with tumor sizes of less than 35 mm and sizes of 35 mm or more (P = .102).
A B
❚Figure 6❚ Recurrence-free survival (RFS) and overall survival (OS) curves in patients with or without LY. A, RFS curves according to lymphatic infiltration of tumor cells (LY). There was no significant difference between patients with or without LY (P = .204). B, OS curves according to LY. There was no significant difference between patients with or without LY (P = .363).
greater depth preoperatively were found to have greater SID and V positivity more frequently (Table 5) . Thus, although preoperative endoscopic diagnosis could not be used to predict LNM, this retrospective analysis should be used to enhance endoscopic findings that reflect deeper SID and can be used to improve the preoperative diagnosis of LNM. In addition, it is necessary to find the preoperative histopathologic findings that were associated with deeper SID and LNM. Our goal is to find the predictive factor for LNM preoperatively in the future on the basis of the present results.
In conclusion, our study suggested that the accurate measurement of SID, in addition to tumor size and LY, might allow for the prediction of LNM. Moreover, tumor size and SID were found to be predictors of a poor prognosis. Evaluation of SID could be conducted as part of routine pathologic examinations of both surgically and endoscopically resected specimens. This understanding of risk factors for LNM paves the way for selecting patients with ESCC who would need additional therapy, which may improve the patients' prognosis in the near future.
